StockCode
688506
Investors
中文 | EN

Great News! Baili Pharma Approved to Establish a National Postdoctoral Research Workstation

时间:2024-08-05

Recently, the Chengdu Human Resources and Social Security Bureau issued a "Notice on the Establishment of a New Batch of Postdoctoral Workstations". After rigorous qualification reviews, expert evaluations, and public announcements conducted by multiple competent departments, including the Ministry of Human Resources and Social Security, Baili Pharma has been granted approval to establish a postdoctoral research workstation!

Postdoctoral research workstations, approved by the Ministry of Human Resources and Social Security, serve as a crucial innovative carrier and platform for nurturing internationally competitive young scientific and technological talents.

企业微信截图_17228192464013.png

企业微信截图_17228192528300.png

企业微信截图_17228192663912.png

                                              

We enthusiastically invite promising doctoral talents to join our research workstation!

Systimmune
Baili Pharmaceutical
Guorui Pharmaceutical
Baili-Bio
Jingxi Pharmaceutical
Hiatt Technology
Company Address:1#, Building 1,No.161, Baili Road, Cross-Strait Science and Technology Industrial Development Park, Wenjiang District, Chengdu City
Postcode:610041
Tel:028-85183639
Sichuan Biokin Pharmaceuticals Co.,Ltd Copyright © 2018 All rights reserved
SICPB No. 17035664-1   
Internet Drug Information Service Qualification Certificate S/N: (C)-FJYX-2022-0343